Amarin (AMRN) highlighted recently published data in the Journal of the American Heart Association showing in a post-hoc analysis of the ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

StockNews.com downgraded shares of Amarin (NASDAQ:AMRN – Free Report) from a hold rating to a sell rating in a research report released on Tuesday morning. Amarin Trading Up 0.6 % Shares of Amarin ...

He will be responsible for leading Amarin’s global finance organization and will report directly to the Company’s Chief Executive Officer, Aaron Berg. Most recently, Mr. F Amarin (AMRN ...

Amarin Corporation announced the publication of new data in the Journal of the American Heart Association, detailing a post-hoc analysis from the REDUCE-IT study, which found that Icosapent Ethyl ...

Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amarin has a twelve month low of $0.43 and a twelve month high of $1.37. The stock has a fifty day simple moving average of $0.51 and a 200 day simple moving average of $0.59. Get Amarin alerts ...